Global Oncology Academy

Bridging Gaps With Blood-Based CRC Screening
Bridging Gaps With Blood-Based CRC Screening
Global Oncology Academy
Bridging Gaps With Blood-Based CRC Screening
- Ryan Quigley
- Aasma Shaukat, MD, MPH
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
Global Oncology Academy
Evolving Strategies in CRC Care: Screening, Treatment, and Equity
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD
Prioritizing Quality of Life in CRC: Key Surgical Considerations
Prioritizing Quality of Life in CRC: Key Surgical Considerations
Global Oncology Academy
Prioritizing Quality of Life in CRC: Key Surgical Considerations
- Ryan Quigley
- Thomas Cataldo, MD
- Sowmya Sharma, MD
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
- Ryan Quigley
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
Project Oncology®
Applying Real-World Data from SABCS 2025 to HR+ HER2- Breast Cancer Care
- Pavani Chalasani, MD, MPH
- Virginia Borges, MD
Predicting Breast Cancer Metastasis with Proteomics
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®
Predicting Breast Cancer Metastasis with Proteomics
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast Cancer
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
- Charles Turck, PharmD, BCPS, BCCCP
- Heather Parsons
How AI Is Transforming Biomarker Development in GI Oncology
How AI Is Transforming Biomarker Development in GI Oncology
Project Oncology®
How AI Is Transforming Biomarker Development in GI Oncology
- William Hall, MD

Medical News

Medical News
Mechanistic Insights into TP53 Inactivation and SCD1 Upregulation Driving Brain Metastasis in Breast Cancer
02/02/2026
Read more
Medical News
Revolutionizing Cancer Therapy: The Impact of Macrophage-Targeting Immunotherapy
02/02/2026
Read more
Medical News
Innovative Nanocarrier Strategies to Overcome Drug Resistance in Esophageal Cancer
02/02/2026
Read more
Medical News
Advancing Hepatic Toxicology: The Miniature Human Liver Platform
02/02/2026
Read more

See more news

CME/CE

Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CE
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
0.25 credits
- Charles E. Geyer Jr., MD, FACP
- Komal Jhaveri, MD, FACP
0.25 credits
Addressing Unmet Needs in Metastatic Uveal Melanoma
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CE
Addressing Unmet Needs in Metastatic Uveal Melanoma
1.00 credit
- Marlana Orloff, MD
- Gregory Daniels, MD, PhD
- Jesse Keller, MD
1.00 credit
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
1.00 credit
- Ryan D. Cassaday, MD
- Daniel J. DeAngelo, MD, PhD
1.00 credit
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program credit
- A.J. Gelderblom, MD, PhD
- Michiel van de Sande, MD, PhD
1.00 program credit

Clinical Practice

How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Project Oncology®
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
- Jennifer Caudle, DO, FACOFP
- Mansi R. Shah, MD
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Advancing HER2-Targeted Therapy in GI Cancers
Advancing HER2-Targeted Therapy in GI Cancers
Project Oncology®
Advancing HER2-Targeted Therapy in GI Cancers
- John H. Strickler, MD
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling

Programs

What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Does BMI Matter in mBC Outcomes?
Does BMI Matter in mBC Outcomes?
Project Oncology®
Does BMI Matter in mBC Outcomes?
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast Cancer
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
- Ashley Baker, MSN, PMHNP
- Nick McAndrew, MD, MSCE
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
On the Frontlines of Metastatic Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
- Jules Cohen, MD